Trials / Active Not Recruiting
Active Not RecruitingNCT05014880
Impact of Time Restricted Eating on Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation
Impact of Time Restricted Eating on Exercise Capacity, Cardiometabolic Parameters, and Trimethylamine N-oxide (TMAO) Levels in Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- University of California, San Diego · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if reducing the number of hours during which one eats each day will help reduce levels of LDL cholesterol and improve other markers of metabolic and cardiovascular health (i.e. blood sugar levels and blood pressure). The study also aims to assess changes in exercise capacity and trimethylamine N-oxide (TMAO) levels in response to Time Restricted Eating (TRE) and Intensive Cardiac Rehabilitation (ICR) versus ICR alone. TMAO is a metabolite, or a substance, produced during digestion and metabolism. Preliminary data illustrates a correlation between high levels of TMAO and higher risk of cardiovascular disease and mortality. We will also be looking at participants' long-term cardiovascular health status after they complete the ICR program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | ICR (Intensive Cardiac Rehabilitation) | Participants in this arm will not have to adopt a 10-hour eating window while taking part in UCSD's 9-week ICR program. |
| BEHAVIORAL | ICR x TRE (Intensive Cardiac Rehabilitation x Time-Restricted Eating) | Participants in this arm will adhere to a daily, consistent 10-hour eating window while undergoing UCSD's 9-week ICR program to see if there is an improvement on cardiometabolic parameters. |
Timeline
- Start date
- 2021-09-02
- Primary completion
- 2023-09-11
- Completion
- 2025-01-31
- First posted
- 2021-08-20
- Last updated
- 2024-08-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05014880. Inclusion in this directory is not an endorsement.